approvals
Age-based approvals for rare diseases can be devastating
For most of my life, my family advocated for therapies to help my twin brother. Although the recent approval of a new drug should give us reason to celebrate, there is still work to be done. My twin brother is 28 years old and suffers from severe Hunter syndrome, also known as mucopolysaccharidosis (MPS) type […]
9 mins read